Literature DB >> 26481827

Emerging Approaches to GPCR Ligand Screening for Drug Discovery.

Punita Kumari1, Eshan Ghosh1, Arun K Shukla2.   

Abstract

The superfamily of G-protein-coupled receptors (GPCRs) represents the largest class of cell surface receptors and, thus, a prominent family of drug targets. Recently, there has been significant progress in determination of GPCR crystal structures. The structure-based ligand discovery of GPCRs is emerging as a powerful path to drug development. Sensor surface-immobilized GPCRs can identify direct receptor-ligand interactions of a range of chemical libraries. This type of screening shows great promise as an alternative strategy for ligand discovery. Here, we summarize the most recent developments of structure- and sensor-based GPCR ligand discovery. We also highlight certain areas where GPCRs harbor great potential for the development of novel therapeutics, emphasizing the strategic approaches that may yield significant breakthroughs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26481827     DOI: 10.1016/j.molmed.2015.09.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  23 in total

Review 1.  Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

Authors:  Madhu Chaturvedi; Justin Schilling; Alexandre Beautrait; Michel Bouvier; Jeffrey L Benovic; Arun K Shukla
Journal:  Trends Biochem Sci       Date:  2018-05-04       Impact factor: 13.807

2.  In vivo biosensors: mechanisms, development, and applications.

Authors:  Shuobo Shi; Ee Lui Ang; Huimin Zhao
Journal:  J Ind Microbiol Biotechnol       Date:  2018-01-29       Impact factor: 3.346

Review 3.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

4.  Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.

Authors:  Seungkirl Ahn; Alem W Kahsai; Biswaranjan Pani; Qin-Ting Wang; Shuai Zhao; Alissa L Wall; Ryan T Strachan; Dean P Staus; Laura M Wingler; Lillian D Sun; Justine Sinnaeve; Minjung Choi; Ted Cho; Thomas T Xu; Gwenn M Hansen; Michael B Burnett; Jane E Lamerdin; Daniel L Bassoni; Bryant J Gavino; Gitte Husemoen; Eva K Olsen; Thomas Franch; Stefano Costanzi; Xin Chen; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-27       Impact factor: 11.205

Review 5.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

6.  Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.

Authors:  Xiao-Feng Xiong; Hang Zhang; Christina R Underwood; Kasper Harpsøe; Thomas J Gardella; Mie F Wöldike; Michael Mannstadt; David E Gloriam; Hans Bräuner-Osborne; Kristian Strømgaard
Journal:  Nat Chem       Date:  2016-07-25       Impact factor: 24.427

7.  Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.

Authors:  Moustafa T Gabr; Mohammed S Abdel-Raziq
Journal:  Medchemcomm       Date:  2018-05-21       Impact factor: 3.597

Review 8.  Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery.

Authors:  Edin Muratspahić; Michael Freissmuth; Christian W Gruber
Journal:  Trends Pharmacol Sci       Date:  2019-04-05       Impact factor: 14.819

9.  Measuring surface expression and endocytosis of GPCRs using whole-cell ELISA.

Authors:  Shubhi Pandey; Debarati Roy; Arun K Shukla
Journal:  Methods Cell Biol       Date:  2018-11-19       Impact factor: 1.441

10.  Purification of native CCL7 and its functional interaction with selected chemokine receptors.

Authors:  Marina V Goncharuk; Debarati Roy; Maxim A Dubinnyi; Kirill D Nadezhdin; Ashish Srivastava; Mithu Baidya; Hemlata Dwivedi-Agnihotri; Alexander S Arseniev; Arun K Shukla
Journal:  Protein Expr Purif       Date:  2020-03-05       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.